Detalles de la búsqueda
1.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
N Engl J Med
; 388(8): 719-732, 2023 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795891
2.
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
Oncologist
; 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38394384
3.
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer.
Cancer
; 127(14): 2587-2594, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798267
4.
Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.
Support Care Cancer
; 27(9): 3209-3217, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31073853
5.
6.
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Ann Intern Med
; 167(5): 341-350, 2017 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28785760
7.
Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth.
Br J Cancer
; 116(3): 324-334, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28056464
8.
9.
High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.
Eur J Clin Pharmacol
; 72(11): 1391-1399, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27561266
10.
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.
Prostate
; 75(8): 836-44, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25683285
11.
Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer.
Oncologist
; 20(12): 1351-2, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26542984
12.
In vivo passage of human prostate cancer cells in mice results in stable gene expression changes affecting numerous cancer-associated biological processes.
Prostate
; 74(5): 537-46, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24435653
13.
Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.
Invest New Drugs
; 32(1): 47-59, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23728939
14.
The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases.
Support Care Cancer
; 22(7): 1765-71, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24515277
15.
Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies.
J Clin Med
; 13(3)2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38337427
16.
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
Clin Genitourin Cancer
; 22(3): 102052, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38461085
17.
177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice.
Curr Oncol
; 31(3): 1400-1415, 2024 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534939
18.
Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments.
J Geriatr Oncol
; 15(3): 101720, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38350343
19.
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.
Eur Urol Oncol
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38582650
20.
TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation.
J Geriatr Oncol
; : 101750, 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521641